Making pregnancy safer for patients with lupus

Area of Science:

• Rheumatology
• Obstetrics
• Immunology

Background:

• Systemic lupus erythematosus (SLE) is a hormone-dependent autoimmune disease primarily affecting young women.
• Hormonal fluctuations, particularly during pregnancy, significantly impact SLE disease activity and course.
• Pregnancy in SLE patients is associated with a high risk of maternal and fetal complications.

Purpose of the Study:

• To review the impact of pregnancy on SLE disease activity.
• To outline risks and management strategies for pregnant women with SLE.
• To provide guidance for optimizing maternal and fetal outcomes.

Main Methods:

• Review of existing literature on SLE and pregnancy.
• Analysis of clinical manifestations, maternal risks, and fetal outcomes in SLE pregnancies.
• Discussion of management guidelines, including disease stability, monitoring, and treatment.

Main Results:

• Pregnancy can trigger clinical flares in 50-60% of SLE patients, often with renal or hematological symptoms.
• Maternal mortality risk is low (2-3%), but fetal loss (25-50%) and preterm birth (25-50%) are common, especially with lupus anticoagulant or renal failure.
• Neonatal lupus is rare (1%), associated with specific autoantibodies (anti-SSA/Ro, anti-SSB/La).

Conclusions:

• Pregnancy in SLE patients requires careful planning, with conception advised only during periods of disease stability (≥6 months).
• Close monitoring, including physical exams, lab tests, and Doppler ultrasound, is vital.
• Antimalarial therapy throughout pregnancy and prompt management of flares are recommended to improve outcomes, though preterm birth remains a significant concern.